
Solid Biosciences (NASDAQ:SLDB) brought in sales totaling $1.93 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 36.1%, resulting in a loss of $25.33 million. Solid Biosciences collected $3.15 million in revenue during Q4, but reported earnings showed a $18.61 million loss.